0001415889-24-006648.txt : 20240305
0001415889-24-006648.hdr.sgml : 20240305
20240305162837
ACCESSION NUMBER: 0001415889-24-006648
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Simmons Jeffrey N
CENTRAL INDEX KEY: 0001479079
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38661
FILM NUMBER: 24720974
MAIL ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elanco Animal Health Inc
CENTRAL INDEX KEY: 0001739104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 825497352
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
BUSINESS PHONE: 877-352-6261
MAIL ADDRESS:
STREET 1: 2500 INNOVATION WAY
CITY: GREENFIELD
STATE: IN
ZIP: 46140
4
1
form4-03052024_090319.xml
X0508
4
2024-03-01
0001739104
Elanco Animal Health Inc
ELAN
0001479079
Simmons Jeffrey N
C/O ELANCO ANIMAL HEALTH INCORPORATED
2500 INNOVATION WAY
GREENFIELD
IN
46140
true
true
false
false
PRESIDENT, CEO AND DIRECTOR
0
Common Stock
2024-03-01
4
A
0
187150
0
A
1415892
D
Common Stock
2024-03-01
4
F
0
48425
16.03
D
1367467
D
Common Stock
45000
I
By Revocable Trust
Employee Stock Option(right to buy)
16.03
2024-03-01
4
A
0
408164
0
A
2034-03-01
Common Stock
408164
408164
D
Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2024, one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.
Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
Grant of stock options vesting as follows: one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.
/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons
2024-03-05